Status not kept up to date
Robot-assisted Esophagectomy Versus Conventional Thoracoscopic Esophagectomy
NCT03094351 · Shanghai Chest Hospital · Updated 5 Feb 2020
- What is being tested
- esophagectomy; esophagectomy
- For
- Esophageal Cancer; Esophageal Carcinoma
- Kind of study
- Tests a treatment or device on volunteers. Phase 3.
- Who can join
- Ages 18 years to 75 years. About 360 people. The full rules are on the registry page.
- Where
- China (6 sites)
- When
- Starts or started 29 July 2017, ends 1 Dec 2024. Registered 29 March 2017.
- Results
- None posted yet.
In the researchers' words
This is the first randomized controlled study to compare the robot-assisted esophagectomy (RAE) to minimally invasive conventional thoracoscopic esophagectomy (CTE). The aim of this trial is to evaluate the safety, risks of the robot-assisted esophagectomy, and to compare the short-term operative outcomes and long-term oncological outcomes between the two surgical treatments.
Sites
- General hospital of eastern theater commandNanjing, Jiangsu, China
- The First Affiliated Hospital of Nanchang UniversityNanchang, Jiangxi, China
- Changhai Hospital, The Second Military Medical UniversityShanghai, China
- Ruijin Hospital, Shanghai Jiao Tong University, School of MedicineShanghai, China
- Shanghai Chest Hospital, Shanghai Jiao Tong UniversityShanghai, China
- Zhongshan Hospital, Fudan UniversityShanghai, China